Artículo original
Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria

Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis

Carlos M. Camposa b cHector M. Garcia-Garciaa Takashi Muramatsua dPedro de Araujo Gonçalvese f gYoshinobu OnumaaDariusz DudekhLeif ThueseniMark W.I. WebsterjPieter Kitslaark lSusan VeldhofmJohan H.C. Reiberk lKoen Niemana nJohn A. OrmistonjPatrick W. Serruyso

a Department of Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, Países Bajos

b Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brasil

c Department of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brasil

d Department of Cardiology, Fujita Health University Hospital, Toyoake, Japón

e Cardiology Department, Hospital de Santa Cruz, CHLO, Lisboa, Portugal

f Hospital da Luz, Cardiovascular Center, ESS, Lisboa, Portugal

g CEDOC, Chronic Diseases Research Center, FCM-NOVA, Lisboa, Portugal

h Jagiellonian University, Cracovia, Polonia

i Department of Cardiology, Aarhus University Hospital, Skejby, Dinamarca

j Auckland City Hospital, Auckland, Nueva Zelanda

k Medis Medical Imaging Systems B.V., Leiden, Países Bajos

l Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, Países Bajos

m Abbott Vascular, Diegem, Bélgica

n Department of Radiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, Países Bajos

o International Centre for Circulatory Health, NHLI, Imperial College London, Londres, Reino Unido

Este artículo está disponible en español

Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria

10.1016/j.recesp.2015.07.031

Rev Esp Cardiol. 2016;69:109-16

This article is available in English

Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis

Carlos M. Campos, Hector M. Garcia-Garcia, Takashi Muramatsu, Pedro de Araujo Gonçalves, Yoshinobu Onuma, Dariusz Dudek, Leif Thuesen, Mark W.I. Webster, Pieter Kitslaar, Susan Veldhof, Johan H.C. Reiber, Koen Nieman, John A. Ormiston, Patrick W. Serruys

10.1016/j.rec.2015.07.027

Rev Esp Cardiol. 2016;69:109-16

Artículo original Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria

Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis

Artículo original
Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria